Terms: = Cervical cancer AND CCND3, P30281, 896, ENSG00000112576 AND Treatment
12 results:
1. Prediction of recurrence risk factors in patients with early-stage cervical cancers by nomogram based on MRI handcrafted radiomics features and deep learning features: a dual-center study.
Zhang Y; Wu C; Du J; Xiao Z; Lv F; Liu Y
Abdom Radiol (NY); 2024 Jan; 49(1):258-270. PubMed ID: 37987856
[TBL] [Abstract] [Full Text] [Related]
2. A Novel Prognostic Risk Model for cervical cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract] [Full Text] [Related]
3. Chrysin inhibits propagation of HeLa cells by attenuating cell survival and inducing apoptotic pathways.
Raina R; Afroze N; Kedhari Sundaram M; Haque S; Bajbouj K; Hamad M; Hussain A
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2206-2220. PubMed ID: 33755959
[TBL] [Abstract] [Full Text] [Related]
4. Multiparametric MRI-Based Radiomics Nomogram for Predicting Lymph Node Metastasis in Early-Stage cervical cancer.
Xiao M; Ma F; Li Y; Li Y; Li M; Zhang G; Qiang J
J Magn Reson Imaging; 2020 Sep; 52(3):885-896. PubMed ID: 32096586
[TBL] [Abstract] [Full Text] [Related]
5. Postoperative chemotherapy for node-positive cervical cancer: Results of a multicenter phase II trial (JGOG1067).
Matoda M; Takeshima N; Michimae H; Iwata T; Yokota H; Torii Y; Yamamoto Y; Takehara K; Nishio S; Takano H; Mizuno M; Takahashi Y; Takei Y; Hasegawa T; Mikami M; Enomoto T; Aoki D; Sugiyama T
Gynecol Oncol; 2018 Jun; 149(3):513-519. PubMed ID: 29661497
[TBL] [Abstract] [Full Text] [Related]
6. Natural history and outcome of neuroendocrine carcinoma of the cervix.
Margolis B; Tergas AI; Chen L; Hou JY; Burke WM; Hu JC; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2016 May; 141(2):247-254. PubMed ID: 26873865
[TBL] [Abstract] [Full Text] [Related]
7. Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.
van Baars R; Griffin H; Wu Z; Soneji YJ; van de Sandt M; Arora R; van der Marel J; Ter Harmsel B; Jach R; Okon K; Huras H; Jenkins D; Quint W; Doorbar J
Am J Surg Pathol; 2015 Nov; 39(11):1518-1528. PubMed ID: 26379150
[TBL] [Abstract] [Full Text] [Related]
8. SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients.
Antonsen SL; Loft A; Fisker R; Nielsen AL; Andersen ES; Høgdall E; Tabor A; Jochumsen K; Fagö-Olsen CL; Asmussen J; Berthelsen AK; Christensen IJ; Høgdall C
Gynecol Oncol; 2013 May; 129(2):298-303. PubMed ID: 23376805
[TBL] [Abstract] [Full Text] [Related]
9. Efficacy, safety, acceptability and affordability of cryotherapy: a review of current literature.
McClung EC; Blumenthal PD
Minerva Ginecol; 2012 Apr; 64(2):149-71. PubMed ID: 22481625
[TBL] [Abstract] [Full Text] [Related]
10. The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy.
Ogino I; Nakayama H; Okamoto N; Kitamura T; Inoue T
Int J Gynecol Cancer; 2006; 16(3):1094-100. PubMed ID: 16803491
[TBL] [Abstract] [Full Text] [Related]
11. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
[TBL] [Abstract] [Full Text] [Related]
12. Risk of recurrence after treatment of severe intraepithelial neoplasia of the cervix. A follow-up of 896 patients.
Robertson JH; Woodend BE; Crozier EH; Patterson A
Ulster Med J; 1987 Oct; 56(2):90-4. PubMed ID: 3445398
[TBL] [Abstract] [Full Text] [Related]
